mRNA vaccine boosters and impaired immune system response

February 3, 2024- by Steven E. Greer, MD

A new peer-review paper shows the rise in IgG4 after the Pfizer/Moderna gene therapy “Vaccine Booster’ shots. (link to PDF) (Made aware of this courtesy of @TheChiefNerd)

“Over the last 18 months, there has been growing evidence of a correlation between the increased prevalence of COVID-19 infection and other pathologies, and the repetition of mRNA COVID-19 vaccine boosters. Recent works…are now evidencing causation to add to correlation, as multiple doses of the mRNA COVID-19 vaccines may result in much higher levels of IgG4 antibodies, or also impaired activation of CD4 + and CD8 + T cells.

Reduced cellular immunity may be the unexpected consequence of having replaced uracil in the genetic code with N1-methyl pseudo uridine, with activation of regulatory T cells caused by the modified protein.

The spike protein on exosomes may persist for more than 4 months. The mRNA of the COVID-19 vaccine was never supposed to only act in the place of injection in the muscle, but rather in the lymph nodes and the spleen. This is central to explaining the many side effects…which include the unintended consequences on the immune system. The lipid nanoparticles encapsulating the mRNA of the COVID-19 vaccines build up in the liver, spleen, adrenal glands, and ovaries. The lipid nanoparticle component is highly inflammatory. Cells that are primed to produce the spike protein are damaged. Spike proteins in the bloodstream damage endothelial cells. SARS-CoV-2 spike protein antibodies may have unintended consequences on other spike proteins. The residual immune memory of the original SARS-CoV-2 virus may prevent efficacy against variants. Signs of reduced immune system response have been many. The findings also indicate potentially significant disruptions in the regulatory control of protein synthesis and cancer surveillance. These disruptions may be linked to neurodegenerative diseases, myocarditis, immune thrombocytopenia, Bell’s palsy, liver disease, impaired adaptive immunity, compromised DNA damage response, and the initiation of tumorigenesis. Multiple doses of the mRNA COVID-19 vaccines lead to higher levels of IgG4 antibodies…Increased IgG4 synthesis due to repeated mRNA vaccine boosters may cause autoimmune diseases, and promote cancer growth and autoimmune myocarditis in susceptible individuals. Impaired CD4 + T cell activation, as seen in conditions like HIV/AIDS, can result in a higher risk of opportunistic infections. For example, mycosis fungoides, which is a type of cutaneous T-cell non-Hodgkin’s lymphoma, is characterized by the abnormal accumulation of CD4 + T cells in the skin. While impaired activation of CD4 + and CD8 + T cells is not considered the direct cause of mycosis fungoides, for which the exact cause is not fully understood, it is believed to play a role in the pathogenesis of the disease…The work casts serious doubt about the protective efficacy of mRNA COVID-19 boosters also bearing significant potential adverse effects.”

This entry was posted in - Biotech, - Opinion, CDC, Congress, FDA, Infectious disease. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *